2871-01-4
CAS 2871-01-4
2871-01-4 (CAS 2871-01-4) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| HC RED NO. 3 | 2469246 | SU | MTHSPL |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 2871-01-4 used for in pharmaceutical contexts?
2871-01-4 (CAS 2871-01-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 2871-01-4?
No adverse-event association or SIDER side-effect rows are rendered for 2871-01-4 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 2871-01-4 also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for HC Red No. 3 with EU status "prohibited".
What clinical phase is 2871-01-4 in?
No phase 1-4 clinical development badge is rendered for 2871-01-4 because the matched compound identifier rows do not contain a max-phase value.